PCN75 COST-EFFECTIVENESS ANALYSIS OF EGFR MUTATION TESTING IN PATIENTS WITH ADVANCED NON SMALL-CELL LUNG CANCER (ANSCLC) TREATED WITH GEFITINIB OR CARBOPLATIN-PACLITAXEL
May 1, 2010, 00:00
10.1016/S1098-3015(10)72164-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)72164-1/fulltext
Title :
PCN75 COST-EFFECTIVENESS ANALYSIS OF EGFR MUTATION TESTING IN PATIENTS WITH ADVANCED NON SMALL-CELL LUNG CANCER (ANSCLC) TREATED WITH GEFITINIB OR CARBOPLATIN-PACLITAXEL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72164-1&doi=10.1016/S1098-3015(10)72164-1
First page :
Section Title :
Open access? :
No
Section Order :
745